LSF is overexpressed in human hepatocellular carcinoma cell lines and over 90% of human hepatocellular carcinoma patient samples, showing significant correlation with stages and grades of the disease (23), and elevated levels of LSF in patient tumors correlate with decreased survival (28). The gene discussed is TFCP2; the disease is hepatocellular carcinoma.